Several have been cited as "severe."
Researchers are developing a new option.
A finance pro explains how to slash costs.
Access to Ozempic has gotten trickier.
Is your prescription on the list?
It could outpace Ozempic, experts say.
A study of pemvidutide had impressive results.
Here's how you can keep losing weight.
New research looks at the rebound effect.
Here's how it affects your body.
He claims it's "repulsive."
The medicine is dropping amid an Ozempic shortage.
Some will go down, but others will go up.
Jennifer Fessler sought emergency treatment.
The highly effective medication is set to compete.
The company admitted "we got it wrong" as it pivots.
And it's not statins.
Mounjaro may have it beat.
The FDA issued a warning about the OTC product.
The FDA warns people should stop using them now.
There are so many finds for just $1.25.
The damages can cost hundreds to fix.
He says they were misdiagnosed at first.
Here's what that means for you.
Thank you for your service.
In every genre.
Now, you'll have the best and latest food and healthy eating news right in your inbox—every single day
Finance experts say you should check these.
This is how the timeline shakes out.